Replies to post #4853 on GB Sciences Inc (GBLX)

[LSU cajun]

Cool brother, thanks for that news,
Finally a grown up on here to chat with.

[jefra1965]

New Deal: NVPURE
It seems to me that NVPURE is running at less than 20% of it's potential, the dispensary is probably shut but it still running using only it's cultivation license producing 350 lbs per month. Next week is the meeting and we will know some more about that deal.
If this is the case, it seems to me like a great deal. To apply the efficiencies I saw and heard of, in my visit to the TECO facility recently, in the NVPURE facility will represent an improved output in a few months time. As an example; the yield per light has increased to 3.5 to 4.5/lt depending on the strain, that's 48% average increase since the last PR at the end of last year. The high THC levels are being constantly replicated. The tissue propagation success rate is above 70% and improving from 20% a year and a half ago. So the time has not been waisted. All the cultivation numbers have dramatically improved since a year ago.. They are capable of doubling the terpenes with the use of new lights they have in trials. All the company needs to do is to replicate the scientific standards in any new facility.
I also had the chance to talk to Mr. Poss and my impression was that he is a very smart, seasoned and prudent business man. I trust his decisions when it comes to move the company forward. To me what is important are sound decisions (NOT SPEED) to get us to that cash flow we need to propel the medical compounds. And here is where the real money may come in.
He mentioned several times about been ready for human trials for the Parkinson/Alzheimer compound in September-October this year.

Financials
When I asked him about the increased operating expenses he explained that a big part of it was a one time non-cash incurred from the vesting of warrants in December that the company has to asume from the difference in prices between the current stock price and the exercise price. That the regular expenses have increased just in proportion to the production (mostly due to new employees). He gave me the numbers close to the range I had estimated so I was very satisfied with his explanation about expenses.

Valuation
Just so you have an idea of where we are. Last September/November the stock was trading between a P/S valuation of 6 (22 cents) to 9 (32 cents) using a forward sales run rate of $8M. This includes the $300K a month of royalty the CURA deal will be producing in a couple of months. Now with this NEW DEAL, the forward sales run rate approaches $30 Million and the current Fwd P/S valuation is 2.7. Less than half the price from last November.

In short we need to give some time for all the projects to be developed and I see this stock @ $4.50 minimum in 18 to 24 months.

I suggest all serious investors to pay a visit to the TECO facility some time this year.

[LSU cajun]

Had good cookout with the directors, got to meet,
John Poss
Ksenia Griswold "pretty hot" nice! lol
Bill Settoon GM of LSU facility
Kevin K. I met at Teco in Vegas
and the German scientist they call him o-be 1 he can eat like a horse! lol

LSU facility on tract will have meds by Sept 1st ,
Kevin said they will be shipping plants to LSU facility very soon,next week or so, I went check out the the facility myself , nice big building nice area. They invited myself and my buddy and his friends to the new facility about mid summer in full operation cant wait for that!
My buddy had 4 friends over and they said they were all going to invest, sounds good, I told Mr. Poss since my trip to Vegas I sold over 1 million shares to new investors and I was just getting started. He said "GREAT"
all in all, really NICE and SHARP people we had a good time, made new friends.
Kevin K was very excited about the new Vegas facility, told me to come check it out if everything goes through on my next visit.